Linked Life Data

18503094

Source:http://linkedlifedata.com/resource/pubmed/id/18503094

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-10-16
pubmed:abstractText
Trisodium citrate (TSC) 30% has been shown in a randomized control trial to be an effective antimicrobial catheter locking solution, able to significantly reduce catheter-related bacteraemia (CRB) in haemodialysis patients. Since that report, the formulation in Europe has been changed to 46.7% TSC without confirmatory data on efficacy. We report a 55 915 patient-day at risk experience in tunnelled lines of 46.7% TSC, emphasizing efficacy and changes in microbiology seen.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1460-2385
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3592-8
pubmed:dateRevised
2009-4-26
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia.
pubmed:affiliation
Renal Unit, St Bartholomew's and the Royal London Hospitals, London, UK.
pubmed:publicationType
Journal Article